 Evelo Biosciences, Inc. EVLO, a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced that management will present a corporate overview at the Stifel 2019 Healthcare Conference on Wednesday, November 20th at 2:25pm EST. A live audio webcast of the presentation will be available on the Investors section of the Evelo website at Evelo Biosciences, Inc. is a clinical stage biotechnology company developing oral biologics that act on cells in the small intestine with systemic therapeutic effects. 